IROS and BioSapien to Launch Oncology Clinical Trials in UAE by 2026
Abu dhabi: IROS, an Abu Dhabi-based contract research organisation and part of the M42 Group, and BioSapien, a pioneering biotech company, have partnered to conduct a landmark oncology clinical trial in Abu Dhabi. The six-month interventional trial is…